BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10800755)

  • 1. In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions.
    Teismann P; Ferger B
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):337-48. PubMed ID: 10800755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress.
    Saphier D; Welch JE
    J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol.
    Shireen E; Qurrat-ul-Ain ; Batool F; Saify ZS; Haleem DJ
    Pak J Pharm Sci; 2002 Jan; 15(1):71-82. PubMed ID: 16414870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Nader MA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
    Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
    Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ; Shireen E; Haleem MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release.
    Lucas G; Bonhomme N; De Deurwaerdère P; Le Moal M; Spampinato U
    Psychopharmacology (Berl); 1997 May; 131(1):57-63. PubMed ID: 9181636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS; Matuszewich L; Hull EM
    Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats.
    Somboonthum P; Matsuda T; Asano S; Sakaue M; Baba A
    Neuropharmacology; 1997; 36(11-12):1733-9. PubMed ID: 9517445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
    Haleem DJ; Khan NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.